-
A287090-100mgSrc tyrosine kinase inhibitor.
-
A287090-10mgSrc tyrosine kinase inhibitor.
-
A287090-25mgSrc tyrosine kinase inhibitor.
-
A287090-50mgSrc tyrosine kinase inhibitor.
-
A287090-5mgSrc tyrosine kinase inhibitor.
-
B287381-10mgIRE1 endonuclease inhibitor: cell permeable.
-
B287381-50mgIRE1 endonuclease inhibitor: cell permeable.
-
Ab170466-100μgBapineuzumab (anti-APP) is an anti-β-amyloid protein (APP) recombinant monoclonal antibody. Bapineuzumab can be used for the research of Alzheimer’s disease (AD).Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.
-
B288442-5mgBAY 293 Negative Control.
-
B287098-10mgBAY 58-2667 hydrochloride.
-
B288058-100mgPotent and selective SMYD2 inhibitor.
-
B288058-25mgPotent and selective SMYD2 inhibitor.